425: Strive, Semler Scientific Merger Communication

Strive, Inc. issued a communication regarding its proposed business combination with Semler Scientific, Inc., highlighting forward-looking statements and associated risks.

Summary

• A communication was posted on X.com by Matthew Cole, Chief Executive Officer of Strive, Inc., on December 23, 2025, concerning Strive's proposed business combination with Semler Scientific, Inc.
• The communication serves as a cautionary statement regarding forward-looking statements related to the proposed transaction, emphasizing inherent risks and uncertainties.
• It highlights that actual results could differ materially from anticipated outcomes due to various factors.
• Strive has filed a Registration Statement on Form S-4 with the SEC, which includes an Information Statement/Proxy Statement/Prospectus, to register Class A common stock to be issued in connection with the merger.
• Investors and stockholders of Semler Scientific are strongly urged to read the Registration Statement and other relevant SEC documents before making any voting or investment decisions.
• The definitive Information Statement/Proxy Statement/Prospectus was sent to Semler Scientific stockholders to seek their approval of the proposed transaction.

Sentiment

Score: 4

Explanation: The filing is primarily a cautionary statement regarding a proposed merger, heavily emphasizing numerous risks and uncertainties that could negatively impact the transaction and future performance. While the intent is a beneficial merger, the document's focus is on potential downsides and legal disclaimers, leading to a cautious sentiment.

Positives

• The proposed business combination aims to achieve strategic and financial benefits for the combined company.
• Management anticipates a successful integration of the combined businesses.

Negatives

• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Integration of the two companies could be more difficult, time-consuming, or costly than projected.
• The proposed transaction may be more expensive or take longer to complete than initially anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities due to the merger process.
• There is a potential for adverse reactions from customers or changes to business or employee relationships following the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price may occur before the closing of the transaction.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the realization of benefits.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

Strive and Semler Scientific anticipate strategic and financial benefits from the proposed transaction, including successful integration and a positive impact on the combined company's future financial performance. However, these are forward-looking statements subject to significant risks and uncertainties, and actual results may differ materially.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., posted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc.
• Strive and Semler Scientific believe that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.

Industry Context

NA

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.

Stakeholder Impact

• Shareholders: Potential dilution from Strive's share issuance; urged to make informed voting/investment decisions; potential for changes in share price.
• Customers: Potential adverse reactions or changes to business relationships.
• Employees: Potential changes to employee relationships.

Next Steps

• Strive and Semler Scientific will continue to work towards the closing of the proposed transaction.
• Stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus and other relevant SEC documents before making voting or investment decisions.
• A definitive Information Statement/Proxy Statement/Prospectus was sent to Semler Scientific stockholders to seek approval.

Key Dates

Recommendation

Given that this filing is a cautionary communication regarding a proposed business combination, heavily emphasizing numerous risks and uncertainties, a 'hold' recommendation is prudent. Investors should carefully review the detailed risks, potential for delays, and dilution outlined, and await further definitive information on the transaction's progress and financial implications before making a 'buy' or 'sell' decision. The focus on potential negative outcomes suggests a need for caution despite the stated strategic intent.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury Strategy, Digital Assets